Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit
LATA
Impact of a Written Document on Post Traumatic Stress Disorder (PTSD) Diagnosed in Family Members After Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit
1 other identifier
interventional
74
1 country
1
Brief Summary
Relatives of patients in situation of withholding and withdrawing life-sustaining therapies often show post traumatic stress disorder (PTSD) (60%)\[1\]. This number is even greater when family members are active in this decision (81%) or when communication is not optimal between medical team and family members. There are several ways to assist families of patients in intensive care units \[2\], amongst them the use of a written document to explain the environment, therapies and possible outcomes. Here the investigators want to test the impact of a written document in the context of end-of-life conference in intensive care units. Specifically, this research addresses wether such written support could decrease 3-months post-traumatic stress disorder, anxiety and depression exhibited by the closest family member or the patient representative.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 29, 2014
CompletedFirst Posted
Study publicly available on registry
December 31, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedDecember 27, 2019
December 1, 2019
3.1 years
December 29, 2014
December 26, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of PTSD
PTSD is assessed with Impact Event Scale (IES) on the family representative
3 months
Secondary Outcomes (9)
Rate of depression
3 months
Rate of anxiety
3 months
Mean level of HADS (anxiety and depression subscales)
3 months
Mean level of IES
3 months
Length of the processus from decision to withhold and withdraw life-sustaining therapies to intensive care unit (ICU) discharge
An average of 6 days
- +4 more secondary outcomes
Study Arms (2)
Written document
EXPERIMENTALAccompanying relatives with a written document when discussing withholding and withdrawing life-sustaining therapies . All other procedures are standard.
Standard
ACTIVE COMPARATORDiscussing withholding and withdrawing life-sustaining therapies following standard procedure without written document
Interventions
The document describes the law and the role of family members and medical team in the decision.
Eligibility Criteria
You may qualify if:
- Medical team anticipates a decision to withhold and withdraw life-sustaining therapies to intensive care unit (ICU) discharge
- verbal consent to participate
- Able to communicate in French
You may not qualify if:
- representant of a patient \< 18 years old
- representant of a patient whose stay in ICU lasted less than 48 hours
- representant of a patient without social security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anesthesiology and Critical Care Depratment, Grenoble University Hospital
Grenoble, 38043, France
Related Publications (3)
Azoulay E, Pochard F, Kentish-Barnes N, Chevret S, Aboab J, Adrie C, Annane D, Bleichner G, Bollaert PE, Darmon M, Fassier T, Galliot R, Garrouste-Orgeas M, Goulenok C, Goldgran-Toledano D, Hayon J, Jourdain M, Kaidomar M, Laplace C, Larche J, Liotier J, Papazian L, Poisson C, Reignier J, Saidi F, Schlemmer B; FAMIREA Study Group. Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med. 2005 May 1;171(9):987-94. doi: 10.1164/rccm.200409-1295OC. Epub 2005 Jan 21.
PMID: 15665319BACKGROUNDSchmidt M, Azoulay E. Having a loved one in the ICU: the forgotten family. Curr Opin Crit Care. 2012 Oct;18(5):540-7. doi: 10.1097/MCC.0b013e328357f141.
PMID: 22914431BACKGROUNDRobin S, Labarriere C, Sechaud G, Dessertaine G, Bosson JL, Payen JF. Information Pamphlet Given to Relatives During the End-of-Life Decision in the ICU: An Assessor-Blinded, Randomized Controlled Trial. Chest. 2021 Jun;159(6):2301-2308. doi: 10.1016/j.chest.2021.01.072. Epub 2021 Feb 5.
PMID: 33549600DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2014
First Posted
December 31, 2014
Study Start
September 1, 2014
Primary Completion
October 1, 2017
Study Completion
March 1, 2018
Last Updated
December 27, 2019
Record last verified: 2019-12